AGP Picks
View all

AGP Executive Report

Your go-to archive of top headlines, summarized for quick and easy reading.

Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.

AI Rules: New Jersey lawmakers are advancing measures to regulate AI in insurance, housing and the workplace, including human oversight for high-stakes decisions and greater transparency from data-center developers. A separate bill would treat chatbots as consumer products, increasing providers’ liability and restricting how they use and store chat logs. Rail Upgrade: The $2.3 billion Portal North Bridge entered full service Nov. 16, replacing a 116-year-old swing bridge that often delayed Northeast Corridor trains. Its fixed span lets boats pass without stopping trains. Biotech: New Brunswick-based Johnson & Johnson plans to acquire Ollin Biosciences for up to $3.3 billion, adding a late-stage eye-disease drug to its pipeline. Health Technology: Quanterix is expanding access to blood-based Alzheimer’s testing in New Jersey through a partnership with Sherman Abrams Laboratory. Shore Medical Center and Shore Physicians Group also selected Oracle Health’s AI-powered electronic health record system.

Biotech Deal: New Brunswick-based Johnson & Johnson agreed to buy Ollin Biosciences for $2.2 billion upfront, adding an experimental eye-disease drug that is headed for Phase 3 trials. Alzheimer’s Testing: Quanterix and Sherman Abrams Laboratory will expand access to blood-based Alzheimer’s tests in New Jersey and nearby areas. South Jersey Health Tech: Shore Medical Center and Shore Physicians Group plan to adopt one AI-powered Oracle Health record system across hospital and outpatient care. Fertility Care: CCRM Fertility of New Jersey in Livingston performed the first commercial procedure using Rejoni’s Juveena hydrogel system, designed to help prevent uterine adhesions from returning after surgery. Cancer Treatment: The FDA approved Biocon’s biosimilar to Perjeta, adding a lower-cost treatment option for HER2-positive breast cancer; Biocon is based in Bridgewater. Air Travel Technology: A faulty router triggered last week’s nationwide FAA ground stop, disrupting flights and costing the U.S. economy billions, according to Transportation Secretary Sean Duffy. The outage renewed calls to upgrade aging air traffic systems, including at Newark.

Air Traffic Technology: The FAA traced Friday’s nationwide ground stop to a router failure during fiber work on a contractor-run network. The four-hour halt disrupted Newark-area travelers and exposed how one network fault can affect air traffic nationwide; officials say there’s no sign of a cyberattack. New Jersey Biotech: Plainsboro-based Novo Nordisk reported new analyses of its investigational CagriSema obesity drug: about 68% of trial participants had lost at least 5% of their weight by week 81. The findings were presented at ObesityWeek. Grid Innovation: New Jersey’s Board of Public Utilities moved to pay residents and businesses to help power the grid, pointing to a broader role for customers in meeting electricity needs. Life Sciences: PharmaLogic plans to acquire Lantheus’ radiopharmaceutical manufacturing business in New Jersey, a deal that could reshape local production capacity. Technology Expansion: Hanwha M&S formed a New Jersey subsidiary to manage U.S. real estate as its technology affiliate Hanwha Vision expands. Wildlife Research: A decades-long osprey recovery effort has helped New Jersey grow from about 50 pairs in the 1970s to 800 occupied nests in 2023, with biologists using nesting platforms and egg transfers.

Air-Traffic Technology: A nationwide FAA ground stop exposed the fragility of aging communications systems after a router problem during an upgrade disrupted thousands of flights. Newark-area travelers were among those stranded as airlines worked to recover. New Jersey Biotech: Plainsboro-based Novo Nordisk reported new analyses of its investigational obesity drug CagriSema, including weight-loss response and physical-function results from a phase 3 trial. Teen Online Safety: New Jersey joined the states behind Meta’s settlement, which will require Instagram and Facebook to add teen safeguards, including overnight usage limits and controls on autoplay. Grid Innovation: The New Jersey Board of Public Utilities is moving to pay residents and businesses to help support the electric grid.

Aviation Technology: A nationwide FAA communications failure grounded flights for more than four hours and left Newark-area travelers facing cancellations and delays. New Jersey Gov. Mikie Sherrill was among those stranded; officials blamed problems during upgrades to aging equipment. Energy and Data Centers: New Jersey voters backed measures restricting data centers, part of a broader backlash over their local impacts. The state Board of Public Utilities is also moving to pay residents and businesses to help power the grid. Biotech: PharmaLogic plans to acquire Lantheus’ radiopharmaceutical manufacturing business and New Jersey facility. Health Research: Plainsboro-based Novo Nordisk presented real-world findings linking Wegovy use with lower reported food-noise scores, while Hackensack Meridian’s medical school announced a $20 million gift for a healthcare-worker wellbeing academy.

Air Traffic Technology: A nationwide FAA communications failure grounded flights for hours and disrupted travel at Newark Liberty and other New York-area airports. Officials say aging equipment was overwhelmed during technology upgrades, renewing calls to modernize the air traffic system. New Jersey Innovation: Succasunna-based Orchard Audio showcased its new Starkrimson 25 integrated amplifier at Capital Audiofest, featuring the company’s gallium-nitride design. Grid Modernization: The New Jersey Board of Public Utilities is moving to pay residents and businesses that help support the electric grid. Life Sciences: PharmaLogic plans to acquire Lantheus’ radiopharmaceutical manufacturing business in New Jersey. Medical Research and Care: Hackensack Meridian School of Medicine will use a $20 million gift to launch an academy focused on health-care professionals’ well-being.

Air Traffic Technology: A nationwide communications failure grounded U.S. departures for more than four hours Friday, disrupting flights at Newark and other New York-area airports. Officials blamed overloaded, aging FAA systems; the outage renewed calls for billions in upgrades. Rutgers Research: Rutgers Health scientists found that a molecule made by gut bacteria rapidly repaired intestinal damage in mice, flies and human cells. The discovery could point to future treatments for inflammatory gut disorders. Grid Innovation: New Jersey’s utility board is moving to pay residents and businesses to help power the grid, expanding ways to manage electricity demand. Life Sciences: PharmaLogic plans to acquire Lantheus’ radiopharmaceutical manufacturing business in New Jersey. NJ Tech Business: SHI International co-founder Leo KoGuan says he won’t make further Nvidia investments without Jensen Huang, who recently stepped down as CEO.

Health AI: Jersey City’s Dyania Health is teaming with NVIDIA to run clinical-reasoning AI on hospital systems, analyzing patient records without sending them outside the hospital firewall. Biotech: Plainsboro-based Novo Nordisk has filed for U.S. and European approval of etavopivat, an investigational sickle cell treatment backed by Phase 3 trial results. Radiopharma: PharmaLogic plans to acquire Lantheus’ Springfield manufacturing facility, expanding New Jersey’s role in production and development of targeted radioactive therapies. Rutgers Research: A Rutgers Health study found that a molecule made by gut bacteria repaired intestinal damage in mice, flies and human cells, pointing to a possible path for treating chronic gut disorders. Grid Innovation: New Jersey is developing PowerUp NJ, a program that would pay residents and businesses to use smart devices, batteries and EV chargers to help ease peak electricity demand.

Research & Connectivity: NSF-backed work by Stevens’ Victor Lawrence and Yu-Dong Yao aims to make wireless communications more reliable for smart factories, where delays can disrupt sensors, AI and robots. Clean Water: At an EPA test site in Edison, researchers demonstrated two ways to identify lead service lines—using electromagnetic signals or vibrations—without digging up pipes. Biotech: Cranbury-based Rocket Pharmaceuticals reported progress on gene-therapy trials for rare heart diseases, while Aptar Pharma’s Boonton facility won approval to handle and manufacture controlled-substance medicines for clinical trials. Energy Costs: A new analysis says data centers covered only 38% of $8.25 billion in grid costs tied to their growth in 2025, leaving households to shoulder much of the bill; New Jersey residents were among those helping fund power upgrades elsewhere. Recycling: New Jersey honored six organizations for sustainability work, including Hoboken’s residential composting program and solar-panel recycling efforts.

AI Safety: A coalition sued five major AI companies seeking to pause development of their most advanced systems; former New Jersey Attorney General Matthew Platkin is representing the groups. Data Center Costs: New research warns AI data centers can push energy costs onto lower-income and rural households, as New Jersey experts weigh rising electricity demand against affordability. Cybersecurity: New Jersey Innovation Institute earned CMMC Level 2 certification, while cybersecurity firm Semperis opened its global headquarters in Hoboken. Clean Mobility: An $8.5 million state-funded partnership aims to expand electric-car sharing across New Jersey. Rutgers Research: Honors College students got hands-on coastal research experience at the university’s Great Bay field station, sampling fish and other marine life.

New Jersey Audio Tech: State-based Orchard Audio has launched its first integrated amplifier, a $3,000 model using gallium-nitride technology and rated at up to 200 watts per channel. Reproductive Health Research: A Rutgers School of Public Health report finds gaps in contraceptive access across New Jersey, with cost, insurance and provider availability affecting whether residents can get their preferred care. Science Discovery: New Jersey researcher Julia Van Etten identified a new species of photosynthetic amoeba from a sample collected in North Carolina. The tiny organism may offer clues to how life evolved. Healthcare Workforce: Hackensack Meridian School of Medicine received a $20 million gift to launch an academy focused on preventing burnout among medical students, residents and early-career nurses. Connectivity: Taara is expanding its wireless optical network for U.S. enterprise and federal customers after a MetLife Stadium deployment in New Jersey linked more than 80,000 spectators and delivered speeds up to 20 gigabits per second.

Microbe Discovery: A New Jersey researcher identified a new photosynthetic amoeba, Paulinella, in a marsh-water sample. The tiny organism could offer clues about how photosynthesis and life evolved. Air Traffic Technology: The FAA’s first digital control towers are operating in Florida and Alaska. The systems were tested at the agency’s William J. Hughes Technical Center in Atlantic City. Radiopharmaceuticals: PharmaLogic agreed to acquire Lantheus’ Springfield manufacturing facility, expanding New Jersey capacity for radiopharmaceutical therapies. Cranberry Science: New Jersey growers are using meat thermometers to trigger sprinkler cooling when berries reach 108°F, protecting a crop worth $16.4 million in 2025. Rutgers is also advancing cranberry breeding and disease research. AI Oversight: New Jersey lawmakers are weighing a bill that would treat AI chatbots as products and impose strict liability on providers.

Business and Innovation: Gov. Mikie Sherrill’s new “New Jersey Means Business” strategy directs agencies to reduce business costs and regulatory delays, while identifying growth sectors and accelerating research and innovation. Cybersecurity: Hoboken-based Semperis has opened its global headquarters in the city, while NJII earned a cybersecurity certification for work with defense contractors. Clean Transportation: An $8.5 million NJDEP-funded partnership will bring electric car sharing to communities across New Jersey. Water Research: Rutgers researchers are advancing cranberry breeding and disease research, supporting a crop central to the state’s agriculture. Clean Water: New Jersey water utilities are investing hundreds of millions of dollars in infrastructure upgrades.

Clean-Tech Investment: Syklea opened its North American headquarters and research lab in Vineland, bringing its microalgae-based industrial carbon-capture technology to the U.S. The company says its system turns captured emissions into usable products without freshwater input. Water Infrastructure: United Flow Technologies added Northern New Jersey water and wastewater specialist Envirolutions to its regional platform, expanding technical services for municipal and industrial customers. Radiopharmaceuticals: PharmaLogic agreed to acquire Lantheus’s Springfield production facility and contract manufacturing business, adding U.S. capacity for therapeutic medicines; the deal awaits regulatory review. Business and Innovation: Gov. Mikie Sherrill’s new statewide strategy directs agencies to reduce barriers, attract investment and accelerate research and innovation. Clean Transportation: An $8.5 million NJDEP-funded initiative will bring electric car-sharing to New Jersey through a partnership between Envoy and LACI.

Cancer Research: A Rutgers-led trial found gentle Tai Chi Qigong and regular exercise each brought small, short-term sleep improvements for older male cancer survivors, with neither approach clearly better. Clean Mobility: Envoy and LACI are launching electric car-sharing across New Jersey through an $8.5 million state-funded initiative. Cybersecurity: Hoboken-based Semperis opened its global headquarters, while NJII earned a certification for meeting federal cybersecurity standards. Data Privacy: New Jersey joined three other states in a settlement of up to $10 million with a health IT firm over a breach affecting at least 13.3 million people; the deal also requires security upgrades. Agricultural Science: Rutgers is advancing cranberry breeding and disease research as growers work to protect a key New Jersey crop.

Clean Mobility: An $8.5 million state grant will support up to 30 shared electric vehicles in Hudson and Bergen counties, with deployments expected to begin soon. Biotech: Jersey City-based Compass Pathways has submitted an FDA application for its investigational psilocybin treatment for depression that has resisted other therapies. Englewood’s 101 Therapeutics also presented promising trial results for a steroid-sparing treatment. Medical Technology: The FDA cleared Onkos Surgical’s NanoCept technology, a milestone for the New Jersey company. Privacy: Flock license-plate cameras at Kean University have brought surveillance concerns to campus, amid growing calls for tighter oversight. Agriculture Research: Rutgers researchers are advancing cranberry breeding and disease research to help protect one of New Jersey’s signature crops.

Fiber Expansion: Greenlight Networks is investing more than $14 million to bring fiber service to over 9,000 Camden County homes and businesses, with construction expected to begin in early 2027. Energy and Data Centers: New Jersey industry leaders weighed grid upgrades, new power sources and affordability; a Stockton University poll found 65% of voters oppose data centers in their hometowns. Health Technology: Hackensack Meridian is the Northeast’s first hospital network to offer Pixclara, an FDA-approved brain cancer imaging drug. Kanvas Biosciences has moved its lab to The HELIX in New Brunswick after raising $48 million. Environmental Testing: Secaucus-based Quest Diagnostics is expanding PFAS and heavy-metal blood and urine testing for consumers. Biotech: A New Jersey-based program led by KOTRA and SK Life Science selected 31 Korean biotech and health technology firms for support entering the U.S. market. Agricultural Research: Rutgers is advancing cranberry breeding and disease research to support a key New Jersey crop. Space History: An Army lab in Wall Township made history in 1946 when Project Diana detected a radar echo from the moon, a milestone for radar astronomy.

AI Chip Cooling: Entegris is expanding into AI-chip heat management, acquiring New Jersey-based Advanced Abrasives and partnering with Element Six on diamond materials for cooling advanced chips. Climate & Agriculture: Rutgers researchers are working to breed better cranberries and fight crop diseases as warming and unpredictable weather challenge Pine Barrens growers. A separate $4.2 million Rutgers grant will support climate resilience and ecological restoration in Woodbridge. Community Solar: New Jersey is adding 10 megawatts of community solar on warehouse roofs. Space Heritage: In 1946, Army engineers at Camp Evans in Wall Township detected a radar echo from the moon—a milestone in radar astronomy and space communications.

AI Chipmaking: New Jersey’s Advanced Abrasives has been acquired by Entegris, which is expanding into diamond-based materials to help cool increasingly powerful AI chips. Entegris also struck a development partnership with Element Six. Aviation Technology: Atlantic City International Airport is among the first sites slated to receive the FAA’s new air traffic information system, replacing decades-old tools as the agency phases out floppy disks by 2028. Rutgers Research: University researchers are breeding and testing cranberry varieties in Chatsworth, while a separate $4.2 million grant will support climate resilience and ecological restoration in Woodbridge. Cybersecurity: The New Jersey Innovation Institute has earned CMMC Level 2 certification, strengthening its credentials in cybersecurity and defense work. Semperis also opened a new global headquarters in Hoboken.

Biopharma Research: Jersey City-based Organon reported that a Veterans Affairs system-wide switch to its biosimilar HADLIMA had a 1.3% switchback rate and cut average pharmacy costs by $8,100 per patient in the first year. Princeton-based Bristol Myers Squibb also shared 56-week trial results for Camzyos in teens with a heart condition. Air Traffic Technology: The FAA plans to replace legacy systems that rely on floppy disks by 2028; Atlantic City International Airport is among the first sites slated for its new information platform. Flood Resilience: Rutgers won $4.2 million to restore wetlands and woodlands along the Woodbridge River, creating natural areas to hold stormwater and reduce flood risk. Work is expected to start in early 2027. Cybersecurity: The New Jersey Innovation Institute earned CMMC Level 2 certification, a milestone for its work supporting national defense.

Sign up for:

Technology Times New Jersey

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Technology Times New Jersey

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.